- New Purchases: BMY, T, NEO,
- Added Positions: AMZN, PYPL, FB, UTX, EEFT, MRK, APD, NVDA, PAYC, PEP, ADP, DIS, ADBE, LOW, ORLY, STZ, BDX, PG, WMT, CRM, NVS, MDLZ, MSFT, HON, XOM, NEE, KO,
- Reduced Positions: UPS, JNJ, FDX, CL, BIIB, NVO, ABBV, AMGN, EMR,
- Sold Out: CTSH, CELG,
For the details of DILLON & ASSOCIATES INC's stock buys and sells, go to https://www.gurufocus.com/guru/dillon+%26+associates+inc/current-portfolio/portfolio
These are the top 5 holdings of DILLON & ASSOCIATES INC- Apple Inc (AAPL) - 111,606 shares, 9.18% of the total portfolio. Shares reduced by 0.23%
- Visa Inc (V) - 121,016 shares, 6.37% of the total portfolio. Shares added by 0.29%
- Stryker Corp (SYK) - 95,368 shares, 5.60% of the total portfolio. Shares reduced by 0.23%
- Abbott Laboratories (ABT) - 211,525 shares, 5.15% of the total portfolio. Shares added by 0.27%
- Automatic Data Processing Inc (ADP) - 87,394 shares, 4.16% of the total portfolio. Shares added by 1.46%
Dillon & Associates Inc initiated holding in Bristol-Myers Squibb Company. The purchase prices were between $49.21 and $64.19, with an estimated average price of $57.47. The stock is now traded at around $63.58. The impact to a portfolio due to this purchase was 0.1%. The holding were 5,684 shares as of .
New Purchase: NeoGenomics Inc (NEO)Dillon & Associates Inc initiated holding in NeoGenomics Inc. The purchase prices were between $19.16 and $29.84, with an estimated average price of $24.01. The stock is now traded at around $32.23. The impact to a portfolio due to this purchase was 0.06%. The holding were 8,000 shares as of .
New Purchase: AT&T Inc (T)Dillon & Associates Inc initiated holding in AT&T Inc. The purchase prices were between $36.82 and $39.63, with an estimated average price of $38.24. The stock is now traded at around $36.96. The impact to a portfolio due to this purchase was 0.06%. The holding were 5,438 shares as of .
Added: Amazon.com Inc (AMZN)Dillon & Associates Inc added to a holding in Amazon.com Inc by 47.69%. The purchase prices were between $1705.51 and $1869.8, with an estimated average price of $1771.74. The stock is now traded at around $2004.20. The impact to a portfolio due to this purchase was 0.29%. The holding were 1,762 shares as of .
Added: Merck & Co Inc (MRK)Dillon & Associates Inc added to a holding in Merck & Co Inc by 161.50%. The purchase prices were between $81.3 and $91.74, with an estimated average price of $86.22. The stock is now traded at around $87.34. The impact to a portfolio due to this purchase was 0.13%. The holding were 8,185 shares as of .
Added: Adobe Inc (ADBE)Dillon & Associates Inc added to a holding in Adobe Inc by 48.53%. The purchase prices were between $261.09 and $331.2, with an estimated average price of $295.33. The stock is now traded at around $358.00. The impact to a portfolio due to this purchase was 0.04%. The holding were 1,417 shares as of .
Sold Out: Cognizant Technology Solutions Corp (CTSH)Dillon & Associates Inc sold out a holding in Cognizant Technology Solutions Corp. The sale prices were between $58.9 and $64.15, with an estimated average price of $61.87.
Sold Out: Celgene Corp (CELG)Dillon & Associates Inc sold out a holding in Celgene Corp. The sale prices were between $97.62 and $110.41, with an estimated average price of $105.2.
Here is the complete portfolio of DILLON & ASSOCIATES INC. Also check out:
1. DILLON & ASSOCIATES INC's Undervalued Stocks
2. DILLON & ASSOCIATES INC's Top Growth Companies, and
3. DILLON & ASSOCIATES INC's High Yield stocks
4. Stocks that DILLON & ASSOCIATES INC keeps buying